QSAM Biosciences Margine lordo

Cos'è Margine lordo di QSAM Biosciences?

Margine lordo di QSAM Biosciences, Inc. è 116.73%

Qual è la definizione di Margine lordo?



Il margine lordo è la differenza tra entrate e costo del venduto, diviso per ricavo ed espresso in percentuale.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Margine lordo di aziende nel Health Care settore su OTC rispetto a QSAM Biosciences

Cosa fa QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Aziende con margine lordo simili a QSAM Biosciences